Trade

with

Agilent Technologies Inc
(NYSE: A)
AdChoices
54.04
+0.98
+1.84%
After Hours :
-
-
-

Open

53.59

Previous Close

53.06

Volume (Avg)

318.13k (2.10M)

Day's Range

53.59-54.04

52Wk Range

49.80-61.22

Market Cap.

17.69B

Dividend Rate (Yield )

0.53 (1.00%)

Beta

1.62

Shares Outstanding

333.51M

P/E Ratio (EPS)

25.91 (2.05)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Diagnostics & Research
Highlights
Analyst Recommendation: Hold
    • Revenue

    • 6.78B

    • Net Income

    • 724.00M

    • Market Cap.

    • 17.69B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 10.04

    • PEG (Price/Earnings Growth) Ratio

    • 1.54

    • Beta

    • 1.62

    • Forward P/E

    • 15.65

    • Price/Sales

    • 2.60

    • Price/Book Value

    • 3.14

    • Price/Cash flow

    • 19.08

      • EBITDA

      • 1.34B

      • Return on Capital %

      • 6.70

      • Return on Equity %

      • 13.28

      • Return on Assets %

      • 6.70

      • Book Value/Share

      • 16.90

      • Shares Outstanding

      • 333.51M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.13 (9/26/2014)

      • Dividend Declaration Date

      • 9/17/2014

      Analyst Recommendation
      10/21/2014
      Hold
        • 1 Year Price Target

        • 65.00

        • Credit Rating

        • A-

        • Analysts

        • 1

        • EPS Estimate

        • 2.58

        • Cashflow Estimate

        • 3.60

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 6.90

          • 21.91

          • Net Income

            YTD/YTD (last year)

          • -37.20

          • -5.55

          • Net Income

            Q/Q (last year)

          • -12.50

          • 0.44

          • Sales (Revenue)

            5-Year Annual Average

          • 3.27

          • 47.82

          • Net Income

            5-Year Annual Average

          • 0.90

          • 4.98

          • Dividends

            5-Year Annual Average

          • -

          • 5.31

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 52.28

            • 42.70

            • Pre-Tax Margin

            • 11.82

            • 11.63

            • Net Profit Margin

            • 10.04

            • 9.55

            • Average Gross Margin

              5-Year Annual Average

            • 52.60

            • 43.76

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 11.30

            • 11.34

            • Average Net Profit Margin

              5-Year Annual Average

            • 10.90

            • 52.13B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.39

              • 0.62

              • Current Ratio

              • 3.06

              • 1.23

              • Quick Ratio

              • 2.08

              • 0.76

              • Interest Coverage

              • 7.97

              • 5.98

              • Leverage Ratio

              • 1.84

              • 2.16

              • Book Value/Share

              • 16.90

              • 14.94

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 25.51

                • 33.44

                • P/E Ratio 5-Year High

                • 29.86

                • 325.07

                • P/E Ratio 5-Year Low

                • 12.00

                • 154.73

                • Price/Sales Ratio

                • 2.56

                • 2.32

                • Price/Book Value

                • 3.09

                • 3.05

                • Price/Cash Flow Ratio

                • 19.08

                • 19.05

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • 25.17

                    • Dividend Date

                    • 9/17/2014

                    • Ex-Dividend Date

                    • 9/26/2014

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • 13.28

                        (17.50)

                      • 9.34

                        (9.80)

                      • Return on Assets %

                        (5-Year Average)

                      • 6.70

                        (7.40)

                      • 4.63

                        (5.44)

                      • Return on Capital %

                        (5-Year Average)

                      • 10.32

                        (11.30)

                      • 5.73

                        (6.77)

                      • Income/Employee

                      • 33.59k

                      • 17.17k

                      • Inventory Turnover

                      • 3.06

                      • 5.07

                      • Asset Turnover

                      • 0.67

                      • 0.48

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      951.00M
                      Operating Margin
                      14.02
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      19.08
                      Ownership

                      Institutional Ownership

                      87.37%

                      Top 10 Institutions

                      36.59%

                      Mutual Fund Ownership

                      46.34%

                      Float

                      99.74%

                      5% / Insider Ownership

                      0.84%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • T. Rowe Price Value Fund

                      •  

                        5,790,000

                      • 13.09

                      • 1.74

                      • Vanguard Health Care Fund

                      •  

                        5,624,200

                      • 0.00

                      • 1.69

                      • T. Rowe Price Mid Cap Growth Fund

                      •  

                        5,500,000

                      • 10.00

                      • 1.65

                      • Vanguard Total Stock Mkt Idx

                      •  

                        5,426,135

                      • 0.39

                      • 1.63

                      • T. Rowe Price Health Sciences Fund

                      •  

                        4,392,330

                      • -0.30

                      • 1.32

                      • Fidelity® Select Health Care Portfolio

                      •  

                        3,940,000

                      • 2.34

                      • 1.18

                      • Vanguard Five Hundred Index Fund

                      •  

                        3,462,457

                      • 0.31

                      • 1.04

                      • Vanguard Institutional Index Fund

                      •  

                        3,378,591

                      • -1.00

                      • 1.01

                      • SPDR® S&P 500 ETF

                      •  

                        3,215,574

                      • -0.67

                      • 0.91

                      • Goldman Sachs Mid Cap Value Fund

                      •  

                        2,696,309

                      • -24.17

                      • 0.81

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • T. Rowe Price Associates, Inc.

                      •  

                        31,222,003

                      • +14.40%

                      • 9.37

                      • Vanguard Group, Inc.

                      •  

                        17,151,132

                      • +2.61%

                      • 5.15

                      • Fidelity Management and Research Company

                      •  

                        16,684,667

                      • +45.14%

                      • 5.01

                      • State Street Corp

                      •  

                        13,100,213

                      • +0.57%

                      • 3.93

                      • Goldman Sachs Asset Management, L.P.

                      •  

                        10,488,361

                      • -3.58%

                      • 3.15

                      • BlackRock Fund Advisors

                      •  

                        9,980,379

                      • -2.27%

                      • 2.99

                      • Wellington Management Company, LLP

                      •  

                        7,136,870

                      • +0.33%

                      • 2.14

                      • State Farm Mutual Automobile Ins CO

                      •  

                        6,921,645

                      • 0.00%

                      • 2.08

                      • Boston Co Asset Management LLC

                      •  

                        4,728,944

                      • -7.38%

                      • 1.42

                      • Northern Trust Investments, N.A.

                      •  

                        4,488,996

                      • -5.46%

                      • 1.35

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Diagnostics & Research

                      Type

                      Slow Growth

                      Style

                      Large Growth

                      Agilent Technologies, Inc was incorporated in Delaware in May 1999. The Company is a measurement company, providing core bio-analytical and electronic measurement solutions to the life sciences, chemical analysis, communications and ...moreelectronics industries. The four operating segments are Life sciences business, Chemical Analysis Business, Diagnostics and Genomics Business and Electronic Measurement Business. Life sciences business provides application-focused solutions that include instruments, software, consumables, and services that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Key product categories in life sciences include: liquid chromatography systems, columns and components; liquid chromatography mass spectrometry systems...more; laboratory software and informatics systems; laboratory automation and robotic systems; dissolution testing; nucleic acid solutions; Nuclear Magnetic Resonance ; Magnetic Resonance Imaging and X-Ray Diffraction systems and services and support for the aforementioned products. The Chemical Analysis business provides application-focused solutions that include instruments, software, consumables, and services that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Key product categories in chemical analysis include: gas chromatography systems, columns and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; software and data systems; vacuum pumps and measurement technologies; services and support for its products. Diagnostics and genomics business provides solutions that include reagents, instruments, software and consumables that enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Its offerings include immunohistochemistry, In Situ Hybridization, Hematoxylin and Eosin Staining, special staining, DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, as well as automated gel electrophoresis-based sample analysis systems. Electronic Measurement Business provides electronic measurement instruments and systems, software design tools and related services that are used in the design, development, manufacture, installation, deployment and operation of electronics equipment, and microscopy products. Related services include start-up assistance, instrument productivity and application services and instrument calibration and repair. The Company’s primary competitors are Bruker Corp., Danaher Corporation, Thermo Fisher Scientific Inc., Waters Corp, PerkinElmer Inc., Shimadzu Corporation, Ventana Medical Systems, Inc., Leica Biosystems Nussloch GmbH, Sakura and Abbott Laboratories. The Company’s businesses are subject to various significant international, federal, state and local regulations, including but not limited to health and safety, packaging, product content, labor and import/export regulations.lessless

                      Key People

                      Ronald S. Nersesian

                      CEO, Divisional/Executive VP, Divisional/President, Divisional

                      Mr. William P. Sullivan

                      CEO/Director

                      James G. Cullen

                      Chairman of the Board/Director

                      Didier Hirsch

                      CFO/Senior VP

                      Solange Glaize

                      Chief Accounting Officer/Other Corporate Officer/Vice President

                      • Agilent Technologies Inc

                      • 5301 Stevens Creek Boulevard

                      • Santa Clara, CA 95051

                      • USA.Map

                      • Phone: +1 408 345-8886

                      • Fax: +1 408 345-8474

                      • home.agilent.com

                      Incorporated

                      1999

                      Employees

                      20,600

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: